Geron Corporation (GERN) Social Stream
GERON CORP (GERN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering GERON CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-11 | 3 | $7 | $3 | $4.5 | $2.01 | 123.88% |
| 2022-05-10 | 4 | $7 | $3 | $4.5 | $2.01 | 123.88% |
| 2022-07-11 | 3 | $7 | $3 | $4.666 | $2.01 | 132.14% |
| 2022-08-12 | 5 | $7 | $3 | $4.2 | $2.01 | 108.96% |
| 2022-10-27 | 6 | $7 | $3 | $4.285 | $2.01 | 113.18% |
| 2022-10-28 | 6 | $7 | $3 | $4.333 | $2.01 | 115.57% |
| 2022-12-13 | 5 | $7 | $3 | $4.333 | $2.01 | 115.57% |
| 2023-01-04 | 5 | $7 | $3 | $4.5 | $2.01 | 123.88% |
| 2023-01-08 | 5 | $7 | $3 | $4.8 | $2.01 | 138.81% |
| 2023-01-09 | 5 | $7 | $3 | $5.2 | $2.01 | 158.71% |
| 2023-03-17 | 4 | $6 | $4 | $5 | $2.01 | 148.76% |
| 2023-08-22 | 5 | $6 | $3 | $4.6 | $2.01 | 128.86% |
| 2023-11-02 | 5 | $6 | $4 | $4.8 | $2.01 | 138.81% |
The Trend in the Analyst Price Target
GERN's average price target has moved up $0.3 over the prior 24 months.
Over the past 42 weeks, GERN's average upside potential has been 98.55%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-09 | 5 | 7 | 3 | 5.2 | 2.95 | 76.27% |
| 2023-03-17 | 5 | 7 | 4 | 5.4 | 2.53 | 113.44% |
| 2023-05-12 | 5 | 6 | 3 | 4.6 | 3.10 | 48.39% |
| 2023-08-22 | 5 | 6 | 3 | 4.6 | 2.28 | 101.75% |
| 2023-11-02 | 5 | 6 | 4 | 4.8 | 1.78 | 169.66% |
GERN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 4 | 1 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
GERN's average broker recommendation rating worsened by 0.2 over the prior 24 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- GERON CORP's average analyst price target is higher than 58.73% of all US stocks.
- In the context of all US stocks, GERON CORP's upside potential (average analyst target price relative to current price) is higher than 1405.45% of them.
- GERN has a higher number of analysts covering the stock than 389.49% of Healthcare stocks.
- GERN has a lower variance in analysts' estimates than -1173.28% of stocks in the small market cap category.
In the Pharmaceutical Products industry, GOVX, ANIX, and PVCT are the three stocks most similar to GERON CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding GERN using the data that counts. Try POWR Ratings for free.